These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24532584)

  • 21. Glycyrrhizin and isoliquiritigenin suppress the LPS sensor toll-like receptor 4/MD-2 complex signaling in a different manner.
    Honda H; Nagai Y; Matsunaga T; Saitoh S; Akashi-Takamura S; Hayashi H; Fujii I; Miyake K; Muraguchi A; Takatsu K
    J Leukoc Biol; 2012 Jun; 91(6):967-76. PubMed ID: 22422925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flavonoids from Radix Tetrastigmae inhibit TLR4/MD-2 mediated JNK and NF-κB pathway with anti-inflammatory properties.
    Liu D; Cao G; Han L; Ye Y; SiMa Y; Ge W
    Cytokine; 2016 Aug; 84():29-36. PubMed ID: 27235587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paclitaxel binding to human and murine MD-2.
    Zimmer SM; Liu J; Clayton JL; Stephens DS; Snyder JP
    J Biol Chem; 2008 Oct; 283(41):27916-27926. PubMed ID: 18650420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sulforaphane inhibits the engagement of LPS with TLR4/MD2 complex by preferential binding to Cys133 in MD2.
    Koo JE; Park ZY; Kim ND; Lee JY
    Biochem Biophys Res Commun; 2013 May; 434(3):600-5. PubMed ID: 23583403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Celastrol blocks binding of lipopolysaccharides to a Toll-like receptor4/myeloid differentiation factor2 complex in a thiol-dependent manner.
    Lee JY; Lee BH; Kim ND; Lee JY
    J Ethnopharmacol; 2015 Aug; 172():254-60. PubMed ID: 26116162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting myeloid differentiation 2 for treatment of sepsis.
    Duan G; Zhu J; Xu J; Liu Y
    Front Biosci (Landmark Ed); 2014 Jun; 19(6):904-15. PubMed ID: 24896325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emodin ameliorated lipopolysaccharide-induced fulminant hepatic failure by blockade of TLR4/MD2 complex expression in D-galactosamine-sensitized mice.
    Yin X; Gong X; Jiang R; Kuang G; Wang B; Zhang L; Xu G; Wan J
    Int Immunopharmacol; 2014 Nov; 23(1):66-72. PubMed ID: 25173984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum amyloid A3 binds MD-2 to activate p38 and NF-κB pathways in a MyD88-dependent manner.
    Deguchi A; Tomita T; Omori T; Komatsu A; Ohto U; Takahashi S; Tanimura N; Akashi-Takamura S; Miyake K; Maru Y
    J Immunol; 2013 Aug; 191(4):1856-64. PubMed ID: 23858030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tailored Modulation of Cellular Pro-inflammatory Responses With Disaccharide Lipid A Mimetics.
    Heine H; Adanitsch F; Peternelj TT; Haegman M; Kasper C; Ittig S; Beyaert R; Jerala R; Zamyatina A
    Front Immunol; 2021; 12():631797. PubMed ID: 33815382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironment.
    Deguchi A; Tomita T; Ohto U; Takemura K; Kitao A; Akashi-Takamura S; Miyake K; Maru Y
    Oncogene; 2016 Mar; 35(11):1445-56. PubMed ID: 26165843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for ProTα-TLR4/MD-2 binding: molecular dynamics and gravimetric assay studies.
    Omotuyi O; Matsunaga H; Ueda H
    Expert Opin Biol Ther; 2015; 15 Suppl 1():S223-9. PubMed ID: 25604147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucosylceramide modifies the LPS-induced inflammatory response in macrophages and the orientation of the LPS/TLR4 complex in silico.
    Mobarak E; Håversen L; Manna M; Rutberg M; Levin M; Perkins R; Rog T; Vattulainen I; Borén J
    Sci Rep; 2018 Sep; 8(1):13600. PubMed ID: 30206272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel roles in human MD-2 of phenylalanines 121 and 126 and tyrosine 131 in activation of Toll-like receptor 4 by endotoxin.
    Teghanemt A; Re F; Prohinar P; Widstrom R; Gioannini TL; Weiss JP
    J Biol Chem; 2008 Jan; 283(3):1257-1266. PubMed ID: 17977838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MD-2-mediated ionic interactions between lipid A and TLR4 are essential for receptor activation.
    Meng J; Lien E; Golenbock DT
    J Biol Chem; 2010 Mar; 285(12):8695-702. PubMed ID: 20018893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and evaluation of the anti-inflammatory activity of novel 8-quinolinesulfonamide derivatives as TLR4/MD-2 inhibitors with efficacy in adjuvant-induced arthritis.
    Liu T; Xing S; Du J; Wang M; Han J; Li Z
    Bioorg Chem; 2021 Sep; 114():105037. PubMed ID: 34120022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Basis of the Functional Differences between Soluble Human Versus Murine MD-2: Role of Val135 in Transfer of Lipopolysaccharide from CD14 to MD-2.
    Vašl J; Oblak A; Peternelj TT; Klett J; Martín-Santamaría S; Gioannini TL; Weiss JP; Jerala R
    J Immunol; 2016 Mar; 196(5):2309-18. PubMed ID: 26826249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-inflammatory action of Athyrium multidentatum extract suppresses the LPS-induced TLR4 signaling pathway.
    Han XZ; Ma R; Chen Q; Jin X; Jin YZ; An RB; Piao XM; Lian ML; Quan LH; Jiang J
    J Ethnopharmacol; 2018 May; 217():220-227. PubMed ID: 29476961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of Toll-like receptors by Burkholderia pseudomallei.
    West TE; Ernst RK; Jansson-Hutson MJ; Skerrett SJ
    BMC Immunol; 2008 Aug; 9():46. PubMed ID: 18691413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of synthetic peptides that inhibit lipopolysaccharide (LPS) binding to myeloid differentiation protein-2 (MD-2).
    Yan H; Gu CG; Xu FL; Wu XH; Yin HH; Hu CX; Zhu XD; Liu F; Ge HJ; Chen LY; Zhang XY; Wang ZG; Xing Z; Li L
    J Immunother; 2013 Apr; 36(3):197-207. PubMed ID: 23502767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative anti-inflammatory characterization of wild fruiting body, liquid-state fermentation, and solid-state culture of Taiwanofungus camphoratus in microglia and the mechanism of its action.
    Liu DZ; Liang HJ; Chen CH; Su CH; Lee TH; Huang CT; Hou WC; Lin SY; Zhong WB; Lin PJ; Hung LF; Liang YC
    J Ethnopharmacol; 2007 Aug; 113(1):45-53. PubMed ID: 17590297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.